A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa
Coagulation Factor VIIa Recombinant
Recombinant-factor-VIIa/rituximab
Coagulation Factor VIIa (Recombinant)